Mohamed M. Radwan is a Senior Research Scientist at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi, USA. He also serves as a Professor at the Faculty of Pharmacy, University of Alexandria, Egypt. He obtained his B.S. in Pharmacy, M.S. in Pharmacy and Pharmaceutical Sciences (Pharmacognosy), and Ph.D. in Pharmacy (Pharmacognosy) from the University of Alexandria in 1994, 2001, and 2005, respectively. Dr. Radwan’s research interests include isolation and structure elucidation of biologically active metabolites from plant, fungal and marine sources, as well as marijuana research. He has worked on many projects funded by the NIH focusing on the isolation and characterization of the components of high-potency marijuana and the evaluation of their pharmacology, and their interaction with CB1 and CB2 receptors. He has also isolated and characterized active secondary metabolites from endophytic fungi, plants, mushrooms, and marines with significant activity against Methicillin-Resistant Staphylococcus aureus (MRSA) microorganisms, malaria and leishmania. He engaged in many projects aiming at the development and validation of the analysis of cannabinoids, terpenes, and flavonoids using UPLC, HPLC, GC/FID, and GC/MS techniques. Currently, he is working in the large-scale production of THC and Other cannabinoids (g to kg quantity) by using chemical and chromatographic techniques.
Mohamed M. Radwan is a Senior Research Scientist at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi, USA. He also serves as a Professor at the Faculty of Pharmacy, University of Alexandria, Egypt. He obtained his B.S. in Pharmacy, M.S. in Pharmacy and Pharmaceutical Sciences (Pharmacognosy), and Ph.D. in Pharmacy (Pharmacognosy) from the University of Alexandria in 1994, 2001, and 2005, respectively. Dr. Radwan’s research interests include isolation and structure elucidation of biologically active metabolites from plant, fungal and marine sources, as well as marijuana research. He has worked on many projects funded by the NIH focusing on the isolation and characterization of the components of high-potency marijuana and the evaluation of their pharmacology, and their interaction with CB1 and CB2 receptors. He has also isolated and characterized active secondary metabolites from endophytic fungi, plants, mushrooms, and marines with significant activity against Methicillin-Resistant Staphylococcus aureus (MRSA) microorganisms, malaria and leishmania. He engaged in many projects aiming at the development and validation of the analysis of cannabinoids, terpenes, and flavonoids using UPLC, HPLC, GC/FID, and GC/MS techniques. Currently, he is working in the large-scale production of THC and Other cannabinoids (g to kg quantity) by using chemical and chromatographic techniques.